| Ticker Symbol: |
MRK - USA Markets |
| Stock Last Traded Price: |
$37.54 |
| Stock Last Traded At: |
12/10/2009 4:00pm |
| Change: |
+0.39 |
| Opened At: |
$37.41 |
| Day Range: |
$37.92 - $37.39 |
| Volume: |
14634193
|
| Page Last Updated: |
12/10/2009 - 4:00pm |
New Page 1
- Drugs May Curb Breast Cancer (at The Wall Street Journal Online)
- Sens. move to block drugmakers from mining Rx data (AP)
- Studies: Bone drugs may help prevent breast cancer (AP)
- An Easy Strategy to Ease Into Options (at Motley Fool)
- A Tale of Two Lillys (at Motley Fool)
- Bears Mauling This Drug Maker's Shares (at CNBC)
- BMO Capital Markets Senior Analyst Sees Strong Performance In PBM Stocks Regardless of U.S. Health Care Legislation (Wall Street Transcript)
- The Next AIDS Crisis (at Forbes.com)
- UPDATE - Lilly suggests profit stumble after patent cliff (at Reuters)
- SEC eyes deals in insider trading probe: sources (Reuters)
- Stocks Doing Right by Shareholders (at Motley Fool)
- Movers roundup: Western Union, Oncothyreon (AP)
- The Public Option Is Dead. Again. Maybe. (at Motley Fool)
- The Fed Is Telling You to Buy Stocks (at Motley Fool)
- Osteoporosis meds may cut breast cancer risk-study (at Reuters)
- Eli Lillys Prognosis: Uncertainty (at Minyanville.com)
- Oncothyreon shares rise on new late-stage study (AP)
- 4 Stocks to Benefit From Health Care Reform: Strategist (at CNBC)
- Eli Lilly Ups 2010 Earnings Forecast (at Fox Business)
- [$$] Pain in the Eurozone (at RealMoney by TheStreet.com)
Drugs May Curb Breast Cancer (at The Wall Street Journal Online)
Sens. move to block drugmakers from mining Rx data (AP)
Drug companies would no longer be able to mine pharmacy records to track which doctors are prescribing their medications, under a proposal unveiled Thursday by two Senate Democrats....
Studies: Bone drugs may help prevent breast cancer (AP)
New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer....
An Easy Strategy to Ease Into Options (at Motley Fool)...
A Tale of Two Lillys (at Motley Fool)...
Bears Mauling This Drug Maker's Shares (at CNBC)...
BMO Capital Markets Senior Analyst Sees Strong Performance In PBM Stocks Regardless of U.S. Health Care Legislation (Wall Street Transcript)
67 WALL STREET, New York - December 10, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online....
The Next AIDS Crisis (at Forbes.com)...
UPDATE - Lilly suggests profit stumble after patent cliff (at Reuters)...
SEC eyes deals in insider trading probe: sources (Reuters)
A new U.S. securities regulatory investigation into potential insider trading began in mid-November with the issuance of subpoenas to a number of hedge funds that may have gotten an advance word on corporate takeovers, said people familiar with the matter....
Stocks Doing Right by Shareholders (at Motley Fool)...
Movers roundup: Western Union, Oncothyreon (AP)
Among the stock activity stories for Thursday, Dec. 10, from AP Financial News: -- Western Union Co. shares shot up a day after the company boosted its annual dividend six-fold and authorized a $1 billion buyback plan....
The Public Option Is Dead. Again. Maybe. (at Motley Fool)...
The Fed Is Telling You to Buy Stocks (at Motley Fool)...
Osteoporosis meds may cut breast cancer risk-study (at Reuters)...
Eli Lillys Prognosis: Uncertainty (at Minyanville.com)
What happens when a patent cliff is within sight....
Oncothyreon shares rise on new late-stage study (AP)
Shares of Oncothyreon Inc. rose Thursday after the company said its partner Merck KGaA started a late-stage study on Stimuvax as a potential lung cancer treatment....
4 Stocks to Benefit From Health Care Reform: Strategist (at CNBC)...
Eli Lilly Ups 2010 Earnings Forecast (at Fox Business)...
[$$] Pain in the Eurozone (at RealMoney by TheStreet.com)... |
